Sample size optimization and initial allocation of the significance levels in group sequential trials with multiple endpoints

被引:5
作者
Gou, Jiangtao [1 ]
机构
[1] Villanova Univ, Dept Math & Stat, Villanova, PA 19085 USA
关键词
multiple tests; multistage designs; power; sample size; trigger; CLOSED TESTING PROCEDURES; CLINICAL-TRIALS; DESIGN; BONFERRONI; FRAMEWORK; FAMILY; SIMES; POWER;
D O I
10.1002/bimj.202000081
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We consider multistage tests of multiple hypotheses under a flexible setting of calendar time and information fraction, focusing on the case where there are two hypotheses under testing. Explicit expressions of statistical powers are derived. With a proof of existence and uniqueness of solution, we develop a numerical method to search the optimal sample size. The proposed method allows us to find the suitable allocation of initial significance level along with the minimum sample size for group sequential designs, with and without hierarchical structures among different endpoints.
引用
收藏
页码:301 / 311
页数:11
相关论文
共 50 条
  • [1] Allocating recycled significance levels in group sequential procedures for multiple endpoints
    Xi, Dong
    Tamhane, Ajit C.
    BIOMETRICAL JOURNAL, 2015, 57 (01) : 90 - 107
  • [2] Sample size determination in group-sequential clinical trials with two co-primary endpoints
    Asakura, Koko
    Hamasaki, Toshimitsu
    Sugimoto, Tomoyuki
    Hayashi, Kenichi
    Evans, Scott R.
    Sozu, Takashi
    STATISTICS IN MEDICINE, 2014, 33 (17) : 2897 - 2913
  • [3] Modification of sample size in group sequential clinical trials
    Cui, L
    Hung, HMJ
    Wang, SJ
    BIOMETRICS, 1999, 55 (03) : 853 - 857
  • [4] Testing multiple primary endpoints in clinical trials with sample size adaptation
    Liu, Yi
    Hu, Mingxiu
    PHARMACEUTICAL STATISTICS, 2016, 15 (01) : 37 - 45
  • [5] Hierarchical testing of multiple endpoints in group-sequential trials
    Glimm, Ekkehard
    Maurer, Willi
    Bretz, Frank
    STATISTICS IN MEDICINE, 2010, 29 (02) : 219 - 228
  • [6] Optimal sample size allocation for two-arm superiority and non-inferiority trials with binary endpoints
    Kirchner, Marietta
    Schuepke, Stefanie
    Kieser, Meinhard
    PHARMACEUTICAL STATISTICS, 2024, 23 (05) : 678 - 686
  • [7] Adaptive sample size calculations in group sequential trials
    Lehmacher, W
    Wassmer, G
    BIOMETRICS, 1999, 55 (04) : 1286 - 1290
  • [8] Sample size determination in clinical trials with multiple co-primary binary endpoints
    Sozu, Takashi
    Sugimoto, Tomoyuki
    Hamasaki, Toshimitsu
    STATISTICS IN MEDICINE, 2010, 29 (21) : 2169 - 2179
  • [9] Sample Size Determination in Group-Sequential Trials Assessing Interim Futility by Intermediate Composite Endpoints
    Nomura, Shogo
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2021, 13 (04): : 492 - 503
  • [10] Sample Size Determination for Equivalence Assessment with Multiple Endpoints
    Sun, Anna
    Dong, Xiaoyu
    Tsong, Yi
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2014, 24 (06) : 1203 - 1214